Komasinski Michael 4
4 · Criteo S.A. · Filed Mar 16, 2026
Research Summary
AI-generated summary of this filing
Criteo CEO Michael Komasinski Receives 141,700-Share Award
What Happened
Michael Komasinski, CEO and Director of Criteo S.A. (CRTO), received a grant/award of 141,700 ordinary shares on March 13, 2026. The shares were reported at a $0.00 acquisition price in the Form 4 (total reported cash value $0) — this is an equity award, not an open‑market purchase or sale. The award is subject to time‑based vesting (see Key Details).
Key Details
- Transaction date: 2026-03-13. Form filed: 2026-03-16 (filing does not show a late-reporting flag).
- Transaction type and amount: Award/Grant (code A) of 141,700 ordinary shares at $0.00.
- Shares owned after transaction: Not disclosed in this Form 4; filing refers to the issuer’s latest definitive proxy for more equity holdings (footnote F3).
- Vesting (footnote F2): 25% vests on the 1‑year anniversary, remainder vests in equal portions quarterly over the following 36 months. Alternate vesting applies (50% at year 2, then quarterly over two years) if a company conversion to a Luxembourg entity is not completed by the first anniversary.
- ADS note (footnote F1): Ordinary shares may be represented by American Depositary Shares (1 ADS = 1 Ordinary Share).
Context
This is a standard time‑vested executive equity award intended to retain and incentivize management; it is not an immediate cash transaction or sale of stock. Such grants give executives future upside if the share price rises as the awards vest, but they do not reflect an immediate market purchase or disposition. For more complete ownership context, consult Criteo’s most recent definitive proxy statement as referenced in the filing.
Insider Transaction Report
- Award
Ordinary Shares
[F1][F2][F3]2026-03-13+141,700→ 361,106 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
- [F2]The shares are subject to time-based vesting as follows: 25% of the shares will vest on the one (1) year anniversary of the grant date, and the remainder of the shares will vest in equal portions at the end of each quarter over the subsequent thirty-six (36) month period. Notwithstanding the foregoing, if the conversion of the Company into a Luxembourg company is not completed before the first anniversary of the grant date, then the shares will be subject to time based vesting as follows: 50% of the shares will vest on the two (2) year anniversary of the grant date and the remainder of the shares will vest in equal portions at the end of each quarter during the two-year period thereafter.
- [F3]For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.